Detterbeck FC. Management of carcinoid tumors. Ann Thorac Surg. 2010;89:998–1005.
Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, Travis WD, Bartsch D, Capdevila J, Costa F, Cwikla J, de Herder W, Delle Fave G, Eriksson B, Falconi M, et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol. 2015;26:1604–20.
Article CAS PubMed Google Scholar
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13715 carcinoid tumors. Cancer. 2003;97:934–59.
Board W. Thoracic Tumours: WHO Classification of Tumours. 5th ed. International Agency for Research on Cancer: Lyon (France); 2021.
Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, Yokose T, Jiang SX, Inoue T, Nakagawa K, Tajima K, Nagai K. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol. 2006;24:70–6. https://doi.org/10.1200/JCO.2005.04.1202.
Varlotto JM, Medford-Davis LN, Recht A, Flickinger JC, Schaefer E, Zander DS, DeCamp MM. Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas? J Thorac Oncol. 2011;6:1050–8. https://doi.org/10.1097/JTO.0b013e318217b6f8.
Fink G, Krelbaum T, Yellin A, Bendayan D, Saute M, Glazer M, Kramer MR. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest. 2001;119:1647–51.
Article CAS PubMed Google Scholar
• Brown LM, Cooke DT, Jett JR, David EA. Extent of resection and lymph node assessment for clinical stage T1aN0M0 typical carcinoid tumors. Ann Thorac Surg. 2018;105(1):207–13 This reference is of importance because includes a large population of patients with TCs, showing the impact of the extent of resection on survival, being the first to also address the issue of how lymph node dissection changes in function of the extent of resection of the primary tumor.
Filosso PL, Guerrera F, Evangelista A, Welter S, Thomas P, Casado PM, Rendina EA, Venuta F, Ampollini L, Brunelli A, Stella F, Nosotti M, Raveglia F, Larocca V, Rena O, Margaritora S, Ardissone F, Travis WD, Sarkaria I, et al. Prognostic model of survival for typical bronchial carcinoid tumours: Analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group. Eur J Cardio-Thorac Surg. 2015;48:441–7. https://doi.org/10.1093/ejcts/ezu495.
Steuer CE, Behera M, Kim S, Chen Z, Saba NF, Pillai RN, Owonikoko TK, Khuri FR, Ramalingam SS. Atypical carcinoid tumor of the lung: A surveillance, epidemiology, and end results database analysis. J. Thorac. Oncol. 2015;10:479–85.
Cardillo G, Sera F, Di Martino M, Graziano P, Giunti R, Carbone L, et al. Bronchial carcinoid tumors: Nodal status and long-term survival after resection. Ann Thorac Surg. 2004;77:1781–5. https://doi.org/10.1016/j.athoracsur.2003.10.089.
Öberg K, Hellman P, Ferolla P, Papotti M. Neuroendocrine bronchial and thymic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23:vii120–3.
National Comprehensive Cancer Network. 2017 NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine Tumors. Version 3; NCCN: Plymouth Meeting, PA, USA; 2017.
Rea F, Rizzardi G, Zuin A, Marulli G, Nicotra S, Bulf R, Schiavon M, Sartori F. Outcome and surgical strategy in bronchial carcinoid tumors: Single institution experience with 252 patients. Eur J Cardio-Thorac Surg. 2007;31:186–91. https://doi.org/10.1016/j.ejcts.2006.10.040.
Filosso PL, Oliaro A, Ruffini E, Bora G, Lyberis P, Asioli S, Delsedime L, Sandri A, Guerrera F. Outcome and prognostic factors in bronchial carcinoids: a single-center experience. J Thorac Oncol. 2013;8:1282–8.
Daddi N, Schiavon M, Filosso PL, Cardillo G, Ambrogi MC, De Palma A, et al. Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids. Eur J Cardiothorac Surg. 2014;45:677–86.
•• Kunz PL, Reidy-Lagunes D, Anthony LB, Bertin EM, Brendtro K, et al. Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors. In: NANETS GUIDELINES. 2020. https://nanets.net/images/2020_Guidelines_Compendium.pdf. Accessed 20 Sept 2022. This reference is of outstanding importance because includes recent consensus guidelines for the optimal management of TCs.
•• Singh S, Bergsland EK, Card CM, Hope TA, Kunz PL, Laidley DT, et al. Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines. J Thorac Oncol. 2020;15:1577–98. https://doi.org/10.1016/j.jtho.2020.06.021 This reference is of outstanding importance because includes recent consensus guidelines for the optimal management of TCs.
•• Shah MH, Goldner WS, Benson AB, Bergsland E, Blaszkowsky LS, Brock P, et al. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19:839–68. https://doi.org/10.6004/jnccn.2021.0032 This reference is of outstanding importance because includes recent consensus guidelines for the optimal management of TCs.
Article CAS PubMed Google Scholar
Stamatis G, Freitag L, Greschuchna D. Limited and radical resection for tracheal and bronchopulmonary carcinoid tumour. Report on 227 cases. Eur J Cardiothorac Surg. 1990;4:527–32.
Article CAS PubMed Google Scholar
Furqan M, Tien YY, Schroeder MC, et al. Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis. J Thorac Dis. 2018;10:5850–9. https://doi.org/10.21037/jtd.2018.09.141.
Article PubMed PubMed Central Google Scholar
Filosso PL, Guerrera F, Falco NR, Thomas P, Garcia Yuste M, Rocco G, Welter S, Moreno Casado P, Rendina EA, Venuta F, Ampollini L, Nosotti M, Raveglia F, Rena O, Stella F, Larocca V, Ardissone F, Brunelli A, Margaritora S, et al. Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids. Eur J Cardiothorac Surg. 2019;55:273–9.
Rahouma M, Kamel M, Narula N, et al. Role of wedge resection in bronchial carcinoid (BC) tumors: SEER database analysis. J Thorac Dis. 2019;11:1355–62. https://doi.org/10.21037/jtd.2019.03.89.
Article PubMed PubMed Central Google Scholar
Yan T, Wang K, Liu J, Zeng Y, Bie F, Wang G, du J. Wedge resection is equal to segmental resection for pulmonary typical carcinoid patients at localized stage: a population-based analysis. PeerJ. 2019;7:e7519. https://doi.org/10.7717/peerj.7519.
Article PubMed PubMed Central Google Scholar
Cattoni M, Vallières E, Brown LM, Sarkeshik AA, Margaritora S, Siciliani A, Filosso PL, Guerrera F, Imperatori A, Rotolo N, Farjah F, Wandell G, Costas K, Mann C, Hubka M, Kaplan S, Farivar AS, Aye RW, Louie BE. Sublobar Resection in the Treatment of Peripheral Typical Carcinoid Tumors of the Lung. Ann Thorac Surg. 2019;108:859–65. https://doi.org/10.1016/j.athoracsur.2019.04.005.
• Bachman KC, Worrell SG, Linden PA, Gray KE, Argote-Greene LM, Towe CW. Wedge Resection Offers Similar Survival to Segmentectomy for Typical Carcinoid Tumors. Semin Thorac Cardiovasc Surg. 2022;34:293–8. https://doi.org/10.1053/j.semtcvs.2021.03.005 This reference is of importance because it shows recent and updated results on the impact of extent of resection on survival for patients TCs.
Rea F, Binda R, Spreafico G, Calabrò F, Bonavina L, Cipriani A, di Vittorio G, Fassina A, Sartori F. Bronchial carcinoids: a review of 60 patients. Ann Thorac Surg. 1989;47:1410–4.
Cavaliere S, Foccoli P, Toninelli C. Curative bronchoscopic laser therapy for surgically resectable tracheobronchial tumors. J Bronchol. 2002;9:90–5.
Sutedja TG, Schreurs AJ, Vanderschueren RG, Kwa B, vd Werf TS, Postmus PE. Bronchoscopic therapy in patients with intraluminal typical bronchial carcinoid. Chest. 1995;107:556–8.
Article CAS PubMed Google Scholar
Luckraz H, Amer K, Thomas L, Gibbs A, Butchart EG. Long-term outcome of bronchoscopically resected endobronchial typical carcinoid tumors. J Thorac Cardiovasc Surg. 2006;132:113–5.
Bertoletti L, Elleuch R, Kaczmarek D, Jean-Francois R, Vergnon JM. Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor. Chest. 2006;130:1405–11.
Fuks L, Fruchter O, Amital A, Fox BD, Rahman NA, Kramer MR. Long-term follow-up of flexible bronchoscopic treatment for bronchial carcinoids with curative intent. Diagn Ther Endosc. 2009;2009:782961.
Hage R, Brutel de la Riviere A, Seldenrijk CA, Van den Bosch JMM. Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol. 2003;10:697–704.
Article CAS PubMed Google Scholar
Rizzardi G, Marulli G, Bortolotti L, Calabrese F, Sartori F, Rea F. Sleeve resections and bronchoplastic procedures in typical central carcinoid tumours. Thorac Cardiovasc Surg. 2008;56:42–5. https://doi.org/10.1055/s-2007-965741.
Article CAS PubMed Google Scholar
DeCaro LF, Paladugu R, Benfield JR, Lovisatti L, Pak H, Teplitz RL. Typical and atypical carcinoids within the pulmonary APUD tumor spectrum. J Thorac Cardiovasc Surg. 1983;86:528–36.
Article CAS PubMed Google Scholar
Cerfolio RJ, Deschamps C, Allen MS, Trastek VF, Pairolero PC. Mainstem bronchial sleeve resection with pulmonary preservation. Ann Thorac Surg. 1996;61:1458–63.
Article CAS PubMed Google Scholar
Lucchi M, Melfi F, Ribechini A, Dini P, Duranti L, Fontanini G, Mussi A. Sleeve and wedge parenchyma-sparing bronchial resections in low-grade neoplasms of the bronchial airway. J Thorac Cardiovasc Surg. 2007;134:373–7.
Blükbas S, Schirren J. Parenchyma-sparing bronchial sleeve resections in trauma, benign and malign diseases. Thorac Cardiovasc Surg. 2010;58:32–7.
留言 (0)